CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AbbVie Inc. v. Roxane Laboratories Inc.

1:12-cv-00457

Overview

Case Number 1:12-cv-00457
Filing Date 2012-04-10
Status Terminated
Termination Date 2013-06-28
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Roxane Laboratories Inc. Operating Company

Represented By

3 Attorneys Listed

Richard K. Herrmann

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Roger J. Chin

Email: roger.chin@lw.com

Mary Matterer

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

AbbVie Inc. Operating Company

Represented By

6 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Barbara R. Rudolph

Email: barbara.rudolph@finnegan.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mindy L. Ehrenfried

Email: mindy.ehrenfried@finnegan.com

Jennifer A. Johnson

Email: jennifer.johnson@finnegan.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 7 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (7 found):
U.S. Courts: 7
U.S. District Court 2017-01-13
1:17-cv-00047

AbbVie Inc. v. Aurobindo Pharma Limited

Asserted Patent
Status: DED
U.S. District Court 2016-05-27
1:16-cv-00398

AbbVie Inc. v. Amneal Pharmaceuticals, LLC

Asserted Patent
Status: DED
U.S. District Court 2015-10-02
1:15-cv-00889

AbbVie Inc. v. Hetero USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-07-18
1:14-cv-00959

AbbVie Inc. v. Aurobindo Pharma Limited

Asserted Patent
Status: DED
U.S. District Court 2013-07-03
2:13-cv-00645

AbbVie Inc. v. Roxane Laboratories Inc.

Asserted Patent
Status: OHSD
U.S. District Court 2013-06-14
1:13-cv-01072

AbbVie Inc. v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-05-15
1:13-cv-00852

AbbVie Inc. v. Hetero USA Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7148359
Polymorph of a pharmaceutical
Filed: 2005-05-04
Issued: 2006-12-12
Expired (Term Ended)
Expires: 2025-05-04
US7364752
Solid dispersion pharamaceutical formulations
Filed: 2000-11-10
Issued: 2008-04-29
Expired (Term Ended) +688d PTA
Expires: 2022-09-29
US6648497
Fiber optic christmas tree stand
Filed: 2001-10-15
Issued: 2003-11-18
Expired (Term Ended)
Expires: 2021-10-15
US6037157
Method for improving pharmacokinetics
Filed: 1996-06-26
Issued: 2000-03-14
Expired (Term Ended)
Expires: 2016-06-26
US6703403
Method for improving pharmacokinetics
Filed: 2001-09-20
Issued: 2004-03-09
Expired (Term Ended)
Expires: 2016-09-09

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

36

Dispositive

35

Granted

1

Denied

0

Pending / Review

30

Motions by Category

Motion to Dismiss 17 Motion to Transfer Venue (28 U.S.C. Β§ 1404) 18 Motion to Stay 1

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
ORDER Adopting [64] Report and Recommendation. Motion to Dismiss (D.I. [24]) is DISMISSED as MOOT. Motion to Dismiss (D.I. [32]) is DENIED. Motion to Substitute...
Entry #65 • 2013-06-18 Document →
Motion to Dismiss Pending / Under Review
REPORT AND RECOMMENDATIONS recommending GRANTING D.I. 34 MOTION to Substitute Party: AbbVie Inc. to replace Abbott Laboratories filed by Abbott Labora...
Entry #64 • 2013-05-28 Document →
Motion to Transfer Venue (28 U.S.C. Β§ 1404) Pending / Under Review
Letter to The Honorable Christopher J. Burke from Mary B. Matterer regarding response to Plaintiff's letter of May 17, 2013 regarding a recent development beari...
Entry #63 • 2013-05-21 Document →
Motion to Transfer Venue (28 U.S.C. Β§ 1404) Pending / Under Review
Letter to The Honorable Christopher J. Burke from Mary B. Graham regarding recent development bearing on Roxane's motion to transfer - re [13] MOTION to Transfe...
Entry #61 • 2013-05-17 Document →
Motion to Dismiss Pending / Under Review
Letter to The Honorable Christopher J. Burke from Mary B. Graham regarding status of case in view of Roxane's motions to transfer to Ohio and to dismiss - re [1...
Entry #51 • 2013-01-17 Document →
Motion to Transfer Venue (28 U.S.C. Β§ 1404) Pending / Under Review
REDACTED VERSION of [46] Notice Of Supplemental Information in Support of its Opposition to Roxane's Motion to Transfer, by Abbott Laboratories. (Fahnestock, De...
Entry #50 • 2012-12-11 Document →

Docket Entries

(92 total)
Pleading / Complaint

COMPLAINT filed against Roxane Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1054193.) - filed by Abbott Laboratories. (Attachments: # (1) Exhibit A-C, # (2) Civil Cover Sheet)(lih)

Entry #1 • 2012-04-10
1
Pleading / Complaint

COMPLAINT filed against Roxane Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1054193.) - filed by Abbott Laboratories. (Attachments: # (1) Exhibit A-C, # (2) Civil Cover Sheet)(lih)

Entry #1 • 2012-04-10
2
Pleading / Complaint

COMPLAINT filed against Roxane Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1054193.) - filed by Abbott Laboratories. (Attachments: # (1) Exhibit A-C, # (2) Civil Cover Sheet)(lih)

Entry #1 • 2012-04-10
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (lih)

Entry #2 • 2012-04-10
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) '359 Patent - Date Patentee(s) Received Notice: 3/24/2011. Date of Expiration of Patent: 7/19/2019. (lih)

Entry #3 • 2012-04-10
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc